Status:
WITHDRAWN
Melatonin Supplementation to Improve Sleep in Patients With Heart Failure
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
American Academy of Sleep Medicine
Conditions:
Heart Failure
Sleep Disorders
Eligibility:
All Genders
35-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether melatonin can improve sleep, quality of life and markers of heart failure in patients with heart failure.
Detailed Description
Heart failure affects nearly 5 million individuals in the United States and constitutes a prime risk factor for morbidity and mortality. Beta-blockers are a class of drugs that form a critical part of...
Eligibility Criteria
Inclusion
- Diagnosed with heart failure NYHA Class 2 or 3
- Currently being treated with beta-blocker
Exclusion
- Diagnosed with obstructive sleep apnea
- Using Fluvoxamine, Warfarin, Nifedipine, or Calcium Channel Blockers
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00869869
Start Date
March 1 2009
End Date
March 1 2011
Last Update
January 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115